GAIN THERAPEUTICS, INC Shares Outstanding (Cover Page)
GAIN THERAPEUTICS, INC (GANX) had Shares Outstanding (Cover Page) of 43.64 million shares as of 2026-07-31, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-07-31: Entity Common Stock, Shares Outstanding 43.64M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 42.65M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 42.24M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 36.10M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 43.64M shares 10-Q · filed 2026-08-11 |
| 2026-04-30 | 42.65M shares 10-Q · filed 2026-05-11 |
| 2026-02-28 | 42.24M shares 10-K · filed 2026-03-26 |
| 2025-10-31 | 36.10M shares 10-Q · filed 2025-11-12 |
| 2025-07-31 | 35.95M shares 10-Q · filed 2025-08-12 |
| 2025-04-30 | 29.56M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 27.79M shares 10-K · filed 2025-03-27 |
| 2024-10-31 | 26.53M shares 10-Q · filed 2024-11-14 |
| 2024-07-31 | 25.54M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 18.05M shares 10-Q · filed 2024-05-14 |
| 2024-02-29 | 16.22M shares 10-K · filed 2024-03-26 |
| 2023-10-31 | 12.91M shares 10-Q · filed 2023-11-14 |
| 2023-07-31 | 12.70M shares 10-Q · filed 2023-08-10 |
| 2023-04-30 | 12.33M shares 10-Q · filed 2023-05-12 |
| 2023-02-28 | 11.88M shares 10-K · filed 2023-03-23 |
| 2022-10-31 | 11.88M shares 10-Q · filed 2022-11-10 |
| 2022-07-31 | 11.88M shares 10-Q · filed 2022-08-08 |
| 2022-04-30 | 11.88M shares 10-Q · filed 2022-05-16 |
| 2022-04-29 | 11.88M shares 10-K/A · filed 2022-05-02 |
| 2022-02-28 | 11.88M shares 10-K · filed 2022-03-25 |
| 2021-10-30 | 11.88M shares 10-Q · filed 2021-11-12 |
| 2021-07-31 | 11.88M shares 10-Q · filed 2021-08-12 |
| 2021-04-30 | 11.88M shares 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |